Vicor (NASDAQ: VICR) insider schedules 200-share Rule 144 sale stock
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Vicor insider Andrew Damico has filed a Form 144 indicating an intent to sell 200 shares of Vicor common stock. The planned sale, through Morgan Stanley Smith Barney on NASDAQ, has an aggregate market value of $29,064, with 32,925,914 Vicor shares outstanding. The 200 shares were acquired the same day via a cash exercise of stock options.
The notice also lists prior Rule 10b5-1 sales by Damico over the past three months, including 14,677 shares sold on 10/22/2025 for $1,211,253 and several smaller transactions. By signing the form, the insider represents that he is not aware of any undisclosed material adverse information about Vicor.
Positive
- None.
Negative
- None.
FAQ
What does Vicor (VICR) insider Andrew Damico plan to sell under this Form 144?
The notice states that Andrew Damico plans to sell 200 shares of Vicor common stock through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $29,064.
What recent Rule 10b5-1 sales by Andrew Damico are disclosed for Vicor (VICR)?
The document lists several Rule 10b5-1 sales, including 14,677 shares sold on 10/22/2025 for $1,211,253, along with multiple smaller transactions between 10/21/2025 and 01/05/2026.
What representation does the Vicor (VICR) insider make when signing Form 144?
By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about Vicor’s current or prospective operations that has not been publicly disclosed.
Which broker is handling the planned Vicor (VICR) Form 144 sale?
The planned sale of 200 Vicor common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York.